PharVision Advisers’s ZenaTech Inc ZENA Stock Holding History

PharVision Advisers’s Portfolio ZENA Stock Details ZENA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40,188	Closed	-$129K	–	681
2025 Q4	$129K	Buy	+40,188	New	+$167K	0.07%	636

Other funds holding ZENA

Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $23.4B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

PharVision Advisers's ZENA Position: Q1 2026 in Review

PharVision Advisers sold out of ZenaTech Inc (ZENA) in Q1 2026, closing a stake of 40,188 shares — an estimated $129K sold.

PharVision Advisers first reported a position in ZENA in Q4 2025 and held it in 1 quarter. The position peaked at $129K in Q4 2025. 37 funds tracked by Wall St. Rank hold ZENA as of Q1 2026.

PharVision Advisers reported no remaining ZenaTech Inc position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 40,188 ZenaTech Inc shares in Q1 2026, an estimated $129K.
PharVision Advisers first reported a position in ZenaTech Inc in Q4 2025 and held it in 1 quarter.
PharVision Advisers's ZenaTech Inc position peaked at $129K in Q4 2025.
37 funds tracked by Wall St. Rank held ZenaTech Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.